HSBC Holdings’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-28,311
Closed -$607K 3553
2021
Q4
$607K Buy
+28,311
New +$558K ﹤0.01% 2338

Other funds holding OCDX

HSBC Holdings's OCDX Position: Q1 2022 in Review

HSBC Holdings sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 28,311 shares — an estimated $607K sold.

HSBC Holdings first reported a position in OCDX in Q4 2021 and held it in 1 quarter. The position peaked at $607K in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • HSBC Holdings reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • HSBC Holdings sold 28,311 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $607K.
  • HSBC Holdings first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 1 quarter.
  • HSBC Holdings's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $607K in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on HSBC Holdings's 13F filing for Q1 2022, filed 16 May 2022.